Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01940120 · ClinicalTrials.gov registry record · NA
EVEREST II Pivotal Study High Risk Registry (HRR)
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01940120 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 78 participants.
The verdict
NCT01940120, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
Prospective, multi-center, single arm registry. Clinical follow-up at discharge, 30 days, 6, 12, 18 and 24, months, and 3, 4 and 5 years. Concurrent Control (CC) group identified retrospectively from the patients screened for the HRR who did not enroll; patient survival determined at 12 months. NCT00209274 (EVEREST II RCT) Intended use Percutaneous reduction of clinically significant mitral regurgitation in symptomatic patients who are considered to be high risk for operative mortality (high surgical risk).
Interventions
- DEVICE Percutaneous mitral valve repair using MitraClip implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2007-02 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01940120
The ClinicalTrials.gov registry entry for NCT01940120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous mitral valve repair using MitraClip implant is the first listed.
NCT01940120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01940120 about?
NCT01940120 is a clinical study titled "EVEREST II Pivotal Study High Risk Registry (HRR)". Prospective, multi-center, single arm registry. Clinical follow-up at discharge, 30 days, 6, 12, 18 and 24, months, and 3, 4 and 5 years. Concurrent Control (CC) group identified retrospectively from the patients screened for the HRR who did not enroll; patient survival determined at 12 months. NCT...
What is the current status of trial NCT01940120?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2007-02. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01940120?
The interventions under investigation include: Percutaneous mitral valve repair using MitraClip implant (DEVICE).
Who is sponsoring clinical trial NCT01940120?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.